Clinical Trial Detail

NCT ID NCT01982448
Title Cisplatin vs Paclitaxel for Triple Neg
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

triple-receptor negative breast cancer

Therapies

Paclitaxel

Cisplatin

Age Groups: adult

No variant requirements are available.